FDA considers limiting authorization of certain monoclonal antibody treatments

4:24pm PST - January 22nd, 2022    ron desantis - CNN

Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the Omicron variant of the coronavirus, a source familiar with the decision-making told CNN.